Financial - Capital Markets
Compare Stocks
5 / 10Stock Comparison
XP vs SCHW vs MS vs RJF vs GS
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
XP vs SCHW vs MS vs RJF vs GS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $7.96B | $157.45B | $307.14B | $30.42B | $290.92B |
| Revenue (TTM) | $19.87B | $26.00B | $103.14B | $15.91B | $126.85B |
| Net Income (TTM) | $5.05B | $8.85B | $16.18B | $2.15B | $16.67B |
| Gross Margin | 9.5% | 75.4% | 55.6% | 88.2% | 41.1% |
| Operating Margin | -19.7% | 29.6% | 17.1% | 28.7% | 14.5% |
| Forward P/E | 1.7x | 14.7x | 16.2x | 13.0x | 15.8x |
| Total Debt | $115.13B | $45.13B | $360.49B | $4.54B | $616.93B |
| Cash & Equiv. | $5.61B | $42.08B | $75.74B | $11.39B | $182.09B |
XP vs SCHW vs MS vs RJF vs GS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| XP Inc. (XP) | 100 | 63.1 | -36.9% |
| The Charles Schwab … (SCHW) | 100 | 246.8 | +146.8% |
| Morgan Stanley (MS) | 100 | 436.7 | +336.7% |
| Raymond James Finan… (RJF) | 100 | 334.1 | +234.1% |
| The Goldman Sachs G… (GS) | 100 | 476.6 | +376.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: XP vs SCHW vs MS vs RJF vs GS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
XP carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 0.06 vs SCHW's 6.42
- 34.1% NII/revenue growth vs SCHW's 1.9%
- Lower P/E (1.7x vs 15.8x), PEG 0.06 vs 1.13
- 3.9% yield, vs RJF's 1.3%
SCHW ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.71, Low D/E 93.3%, current ratio 0.54x
- Beta 0.71 vs XP's 1.68, lower leverage
MS is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 11 yrs, beta 1.36, yield 2.0%
- 7.4% 10Y total return vs GS's 5.4%
- Beta 1.36, yield 2.0%, current ratio 0.66x
RJF is the clearest fit if your priority is bank quality.
- NIM 2.4% vs GS's 0.5%
GS is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 17.0%, EPS growth 77.3%
- Efficiency ratio 0.3% vs RJF's 0.6% (lower = leaner)
- +68.3% vs SCHW's +6.7%
- Efficiency ratio 0.3% vs RJF's 0.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.1% NII/revenue growth vs SCHW's 1.9% | |
| Value | Lower P/E (1.7x vs 15.8x), PEG 0.06 vs 1.13 | |
| Quality / Margins | Efficiency ratio 0.3% vs RJF's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 0.71 vs XP's 1.68, lower leverage | |
| Dividends | 3.9% yield, vs RJF's 1.3% | |
| Momentum (1Y) | +68.3% vs SCHW's +6.7% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs RJF's 0.6% |
XP vs SCHW vs MS vs RJF vs GS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
XP vs SCHW vs MS vs RJF vs GS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SCHW leads in 1 of 6 categories
XP leads 1 • RJF leads 1 • GS leads 1 • MS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SCHW leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GS is the larger business by revenue, generating $126.9B annually — 8.0x RJF's $15.9B. SCHW is the more profitable business, keeping 22.9% of every revenue dollar as net income compared to GS's 11.3%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $19.9B | $26.0B | $103.1B | $15.9B | $126.9B |
| EBITDAEarnings before interest/tax | -$1.7B | $12.8B | $26.3B | $2.9B | $23.4B |
| Net IncomeAfter-tax profit | $5.1B | $8.9B | $16.2B | $2.1B | $16.7B |
| Free Cash FlowCash after capex | $17.9B | $9.7B | -$6.7B | $1.5B | $15.8B |
| Gross MarginGross profit ÷ Revenue | +9.5% | +75.4% | +55.6% | +88.2% | +41.1% |
| Operating MarginEBIT ÷ Revenue | -19.7% | +29.6% | +17.1% | +28.7% | +14.5% |
| Net MarginNet income ÷ Revenue | +22.7% | +22.9% | +13.0% | +13.4% | +11.3% |
| FCF MarginFCF ÷ Revenue | +54.6% | +7.9% | -2.0% | +14.1% | -12.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +13.8% | +41.5% | +48.9% | +15.3% | +45.8% |
Valuation Metrics
XP leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.5x trailing earnings, XP trades at a 61% valuation discount to SCHW's 29.6x P/E. Adjusting for growth (PEG ratio), XP offers better value at 0.37x vs SCHW's 12.94x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8.0B | $157.5B | $307.1B | $30.4B | $290.9B |
| Enterprise ValueMkt cap + debt − cash | $30.1B | $160.5B | $591.9B | $23.6B | $725.8B |
| Trailing P/EPrice ÷ TTM EPS | 11.54x | 29.64x | 24.28x | 14.98x | 23.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 1.73x | 14.71x | 16.24x | 12.97x | 15.79x |
| PEG RatioP/E ÷ EPS growth rate | 0.37x | 12.94x | 2.73x | 0.70x | 1.65x |
| EV / EBITDAEnterprise value multiple | — | 17.59x | 26.01x | 4.96x | 34.91x |
| Price / SalesMarket cap ÷ Revenue | 1.99x | 6.06x | 2.98x | 1.91x | 2.29x |
| Price / BookPrice ÷ Book value/share | 2.60x | 3.36x | 2.95x | 2.55x | 2.56x |
| Price / FCFMarket cap ÷ FCF | 3.64x | 76.81x | — | 13.54x | — |
Profitability & Efficiency
RJF leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SCHW delivers a 2.9% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $13 for GS. RJF carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to XP's 5.74x. On the Piotroski fundamental quality scale (0–9), SCHW scores 7/9 vs XP's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +21.4% | +2.9% | +14.6% | +16.4% | +12.6% |
| ROA (TTM)Return on assets | +1.3% | +2.3% | +1.2% | +2.5% | +0.9% |
| ROICReturn on invested capital | -2.6% | +6.0% | +2.9% | +20.9% | +1.9% |
| ROCEReturn on capital employed | -2.8% | +9.5% | +3.8% | +22.0% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 5 | 6 | 4 |
| Debt / EquityFinancial leverage | 5.74x | 0.93x | 3.42x | 0.36x | 5.06x |
| Net DebtTotal debt minus cash | $109.5B | $3.1B | $284.7B | -$6.8B | $434.8B |
| Cash & Equiv.Liquid assets | $5.6B | $42.1B | $75.7B | $11.4B | $182.1B |
| Total DebtShort + long-term debt | $115.1B | $45.1B | $360.5B | $4.5B | $616.9B |
| Interest CoverageEBIT ÷ Interest expense | 8.55x | 3.05x | 0.44x | 1.57x | 0.31x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $26,886 today (with dividends reinvested), compared to $5,000 for XP. Over the past 12 months, GS leads with a +68.3% total return vs SCHW's +6.7%. The 3-year compound annual growth rate (CAGR) favors GS at 44.0% vs XP's 12.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.5% | -12.1% | +7.2% | -5.0% | +2.9% |
| 1-Year ReturnPast 12 months | +10.0% | +6.7% | +61.7% | +7.5% | +68.3% |
| 3-Year ReturnCumulative with dividends | +43.3% | +93.3% | +141.8% | +85.8% | +198.5% |
| 5-Year ReturnCumulative with dividends | -50.0% | +31.8% | +142.9% | +80.8% | +168.9% |
| 10-Year ReturnCumulative with dividends | -38.1% | +253.1% | +743.3% | +396.8% | +541.0% |
| CAGR (3Y)Annualised 3-year return | +12.8% | +24.6% | +34.2% | +22.9% | +44.0% |
Risk & Volatility
Evenly matched — SCHW and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
SCHW is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than XP's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.1% from its 52-week high vs SCHW's 82.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 0.71x | 1.36x | 1.04x | 1.47x |
| 52-Week HighHighest price in past year | $23.11 | $107.50 | $194.83 | $177.66 | $984.70 |
| 52-Week LowLowest price in past year | $15.61 | $83.62 | $119.99 | $138.82 | $558.21 |
| % of 52W HighCurrent price vs 52-week peak | +83.0% | +82.4% | +99.1% | +86.9% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 44.8 | 40.1 | 59.9 | 50.4 | 55.7 |
| Avg Volume (50D)Average daily shares traded | 5.1M | 9.3M | 5.3M | 1.3M | 2.0M |
Analyst Outlook
Evenly matched — XP and RJF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: XP as "Buy", SCHW as "Buy", MS as "Buy", RJF as "Hold", GS as "Hold". Consensus price targets imply 34.4% upside for SCHW (target: $119) vs 4.7% for GS (target: $981). For income investors, XP offers the higher dividend yield at 3.91% vs RJF's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $23.50 | $119.11 | $203.00 | $169.00 | $980.78 |
| # AnalystsCovering analysts | 9 | 50 | 52 | 24 | 55 |
| Dividend YieldAnnual dividend ÷ price | +3.9% | +1.4% | +2.0% | +1.3% | +1.4% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 11 | 22 | 12 |
| Dividend / ShareAnnual DPS | $3.72 | $1.24 | $3.81 | $2.01 | $13.48 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | 0.0% | +1.4% | +4.2% | +3.5% |
SCHW leads in 1 of 6 categories (Income & Cash Flow). XP leads in 1 (Valuation Metrics). 2 tied.
XP vs SCHW vs MS vs RJF vs GS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is XP or SCHW or MS or RJF or GS a better buy right now?
For growth investors, XP Inc.
(XP) is the stronger pick with 34. 1% revenue growth year-over-year, versus 1. 9% for The Charles Schwab Corporation (SCHW). XP Inc. (XP) offers the better valuation at 11. 5x trailing P/E (1. 7x forward), making it the more compelling value choice. Analysts rate XP Inc. (XP) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — XP or SCHW or MS or RJF or GS?
On trailing P/E, XP Inc.
(XP) is the cheapest at 11. 5x versus The Charles Schwab Corporation at 29. 6x. On forward P/E, XP Inc. is actually cheaper at 1. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: XP Inc. wins at 0. 06x versus The Charles Schwab Corporation's 6. 42x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — XP or SCHW or MS or RJF or GS?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +168. 9%, compared to -50. 0% for XP Inc. (XP). Over 10 years, the gap is even starker: MS returned +743. 3% versus XP's -38. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — XP or SCHW or MS or RJF or GS?
By beta (market sensitivity over 5 years), The Charles Schwab Corporation (SCHW) is the lower-risk stock at 0.
71β versus XP Inc. 's 1. 68β — meaning XP is approximately 137% more volatile than SCHW relative to the S&P 500. On balance sheet safety, Raymond James Financial, Inc. (RJF) carries a lower debt/equity ratio of 36% versus 6% for XP Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — XP or SCHW or MS or RJF or GS?
By revenue growth (latest reported year), XP Inc.
(XP) is pulling ahead at 34. 1% versus 1. 9% for The Charles Schwab Corporation (SCHW). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to 6. 2% for Raymond James Financial, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — XP or SCHW or MS or RJF or GS?
The Charles Schwab Corporation (SCHW) is the more profitable company, earning 22.
9% net margin versus 11. 3% for The Goldman Sachs Group, Inc. — meaning it keeps 22. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SCHW leads at 29. 6% versus -19. 7% for XP. At the gross margin level — before operating expenses — RJF leads at 88. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is XP or SCHW or MS or RJF or GS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, XP Inc. (XP) is the more undervalued stock at a PEG of 0. 06x versus The Charles Schwab Corporation's 6. 42x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, XP Inc. (XP) trades at 1. 7x forward P/E versus 16. 2x for Morgan Stanley — 14. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SCHW: 34. 4% to $119. 11.
08Which pays a better dividend — XP or SCHW or MS or RJF or GS?
All stocks in this comparison pay dividends.
XP Inc. (XP) offers the highest yield at 3. 9%, versus 1. 3% for Raymond James Financial, Inc. (RJF).
09Is XP or SCHW or MS or RJF or GS better for a retirement portfolio?
For long-horizon retirement investors, The Charles Schwab Corporation (SCHW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
71), 1. 4% yield, +253. 1% 10Y return). XP Inc. (XP) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SCHW: +253. 1%, XP: -38. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between XP and SCHW and MS and RJF and GS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: XP is a small-cap high-growth stock; SCHW is a mid-cap quality compounder stock; MS is a large-cap high-growth stock; RJF is a mid-cap deep-value stock; GS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.